Consult these resources from our team of experts
Articles
- PDF Streamline Early-Stage Development to Reach the Clinic Faster
- PDF Solubility Enhancement Of Itraconazole By Amorphous Solid Dispersion Approach Using Spray Drying
- PDF Overcoming The Challenges Of Pediatric Formulation
- PDF Maintaining a Drug’s Bioavailability and Masking Taste With Microencapsulation
- PDF Taste Masking 101: A Q&A With The Experts
- PDF Microspheres Help Fill An Unmet Need In Long-Acting Contraceptives
- PDF Managing Poor Solubility with Cutting-Edge Formulation Approaches
- PDF Taste Masking 101: Optimize Taste and Improve Patient Outcomes
- PDF Formulation Considerations for Pediatric Populations: Finding the Right Dosage Form for Better Adherence
- PDF Path Towards Efficient Pediatric Formulation Development
- PDF How to Achieve Precise and Flexible Dosing with Multiparticulates
- PDF Probing the Source of an Unstable Impurity and Controlling Its Formation at Release
- PDF Dedicated Dialogue: Improved Drug Delivery with Precision Particle Fabrication
- PDF Dissolution Development of Parvulet® Technology Oral Tablets Scientific Briefing
- PDF Formulation of Monodisperse Controlled-Release Quetiapine Microspheres Nonoyama Scientific Briefing
- PDF Formulation of Aqueous Core Poly(lactic acid) Microcapsules N. Dormer Scientific Briefing
- PDF Microcaps® Coacervation White Paper
- PDF Adare Interactive Overview
Case Studies
- PDF Case Study: Creating a Taste Masked and Easily Swallowed Malaria Drug for Elderly Patients
- PDF Case Study: An Easy-To-Swallow Depression Drug For Elderly Patients
- PDF Case Study: Stable Microcaps® Formulation Masks Bitter HIV Drug for Young Children
- PDF Case Study: Dry Syrup Formulation Masks Bitter Taste in Easy-to-Swallow Suspension
- PDF Microcaps® Outperforms Standard Bead Intermediate Formulations
- PDF Finding Impurities and Controlling Formations at Release
- PDF Case Study: Microcaps® Exceeds Stringent Requirements Beyond Taste Masking
- PDF Case Study: Zenpep-MMTS™ Minitabs Delivers Child-Friendly Dosing for Toddlers
Webinars
- PDF Selecting a CDMO: A Guide to Successful Collaboration
- Webinar Effective Strategies For Pediatric Formulation Development
- Webinar Taste Masking 101 (Session 4 of 4): Sensory and Performance Evaluation
- Webinar Integrated Solutions From Start to Finish: Outsourced Pharma March 2022
- Webinar Taste Masking 101 (Session 3 of 4): Challenges with Pediatric Flavors for Taste Enhancement & Modulation
- Webinar Injectable Drug Delivery Market
- Webinar Strategies for Effective Patient-Centric Dosage Formulations
- Webinar Taste Masking 101 (Session 2 of 4): Applications and Technologies
- Webinar Taste Masking 101 (Session 1 of 4): Optimize Taste and Improve Patient Treatment Outcomes
- Webinar Minitablets – a Patient Centric Dosage Form
- Webinar Formulation & Drug Development Trends
- Webinar On-Demand Webinar: Patient Adherence for Isolated Populations During the Pandemic
- Webinar Advancing Medication Adherence for Pediatrics and Patients with Dysphagia
- Webinar Life Cycle Management Strategies for Patients with Swallowing Disorders
Videos
- Video Adare Corporate Video
- Video ADARE Virtual Tour – Vandalia, OH
- Video ADARE Technologies
- Video Giant-A86 Blister Packaging Line
- Video #ChatsWithChaudhrey with Adare Pharma Soutions, CEO, Vivek Sharma on their acquisition on Frontida BioPharma
- Video AdvaTab® Technology
- Video Diffucaps® Technology
- Video Microcaps® Technology
- Video Minitabs™ Technology
- Video Parvulet® Technology
- Video Virtual Tour Teaser
- Video Access to Choice: Long Acting Injectables for Contraceptives BBC Final Video
- Video CPhI Festival of Pharma Roundtable
Leadership Interviews
- PDF Global Business Report Interviews CEO Tom Sellig
- PDF Harris Williams Discusses Growth With the CEO of Adare Pharma Solutions
- PDF The Evolution Of A CDMO
- Video CEO Tom Sellig Interview With Life Science Marketing Radio
- PDF The Journey To Become A Full-Service Provider: An Interview With Adare CEO Tom Sellig
- Audio CEO of Adare Pharma, Tom Sellig, Articulating Core Values During a High-Stakes Interview
- PDF A New End-To-End CDMO Takes Shape: What Does Adare’s Acquisition of Frontida Mean for the Industry?
Speaker Presentations
2022
2020
- PDF Orally-Disintegrating Dosage Forms With Taste Masked Multiparticulates
- PDF Pharma Synergy Presentation
- PDF Taste-Masked Dosage Form for Pediatric Oral Delivery: An Industrial Perspective
- PDF Innovations in Dosage Form Design: Pediatrics & Patients with Dysphagia
- PDF Functional Release Multiparticulates Slam: Can the young Optimµm® technology challenge established Microcaps® and Würster coating technologies?
- PDF Long-Acting Injectables: Stratµm™
- PDF Patient-Centric Dosage Forms: Strategies for Acceptance and Adherence in Pediatric and Geriatric Population
